SMAD4 and digestive system carcinoma: These reuslts are consistent with those of previous studies, showing that Smad4 inhibits VEGF expression and suppresses tumorigenicity through the inhibition of angiogenesis in human pancreatic and gastrointestinal carcinoma cells (68–70).